Salarius Announces Closing of $23 Million Underwritten Public Offering of Common Stock Following Full Exercise of Over-Allotment Option
March 08, 2021 16:05 ET
|
Salarius Pharmaceuticals, Inc.
HOUSTON, March 08, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric...
Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2021 and Recent Developments
March 08, 2021 16:05 ET
|
Avid Bioservices, Inc
-- Third Quarter Revenue Increased 61% to $21.8 Million -- -- Signed $74 Million in New Orders to End the Quarter with a Backlog of $120 Million -- -- First Phase of Myford Expansion on Target,...
vTv Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
March 08, 2021 16:05 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., March 08, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for...
Full House Resorts Announces Strong Fourth Quarter Results
March 08, 2021 16:05 ET
|
Full House Resorts, Inc.
- Operating Income Improved to $7.7 Million from an Operating Loss of $0.4 Million;Net Income Improved to $3.5 Million from a Net Loss of $4.1 Million;Adjusted EBITDA More Than Quadrupled from...
Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021
March 08, 2021 16:05 ET
|
Prothena Corporation plc
Superior profile of novel anti-tau antibody PRX005 supports advancement for the potential treatment of Alzheimer’s diseaseNew analyses of prasinezumab continue to support potential disease modifying...
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Issues 2021 Financial Guidance
March 08, 2021 16:03 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
Altimmune to Present at Upcoming Conferences
March 08, 2021 16:01 ET
|
Altimmune, Inc.
GAITHERSBURG, Md., March 08, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will present...
Gevo to Report Fourth Quarter 2020 Financial Results Earlier
March 08, 2021 16:01 ET
|
Gevo, Inc.
ENGLEWOOD, Colo., March 08, 2021 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) announced today that it has rescheduled the release of its fourth quarter 2020 financial results ended December 31,...
AltruBio’s Neihulizumab Granted Fast Track Designation by the FDA for Steroid Refractory Acute Graft Versus Host Disease
March 08, 2021 16:01 ET
|
AltruBio Inc.
REDWOOD CITY, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company, announced today that the U.S. Food and Drug Administration...
Usio to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
March 08, 2021 16:01 ET
|
Usio, Inc.
SAN ANTONIO, March 08, 2021 (GLOBE NEWSWIRE) -- Usio, Inc. (NASDAQ: USIO), an integrated electronic payment solutions provider, announced today that Louis Hoch, Chief Executive Officer, has been...